Addus HomeCare Co. (NASDAQ:ADUS) Shares Sold by HighTower Advisors LLC

HighTower Advisors LLC cut its stake in Addus HomeCare Co. (NASDAQ:ADUS) by 30.2% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,908 shares of the company’s stock after selling 1,260 shares during the period. HighTower Advisors LLC’s holdings in Addus HomeCare were worth $395,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently bought and sold shares of the stock. Wasatch Advisors LP raised its stake in shares of Addus HomeCare by 11.8% in the third quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock worth $138,782,000 after purchasing an additional 110,010 shares during the last quarter. Point72 Asset Management L.P. increased its holdings in Addus HomeCare by 73.4% in the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock worth $86,598,000 after buying an additional 315,602 shares during the period. Dimensional Fund Advisors LP increased its holdings in Addus HomeCare by 0.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after buying an additional 5,421 shares during the period. Principal Financial Group Inc. lifted its stake in Addus HomeCare by 17.5% during the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock valued at $67,293,000 after acquiring an additional 75,409 shares during the period. Finally, WCM Investment Management LLC boosted its holdings in shares of Addus HomeCare by 2.9% in the 3rd quarter. WCM Investment Management LLC now owns 498,279 shares of the company’s stock valued at $65,250,000 after acquiring an additional 13,938 shares during the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Addus HomeCare Stock Performance

Shares of NASDAQ ADUS opened at $131.40 on Monday. The firm has a fifty day moving average of $125.86 and a 200 day moving average of $125.07. The firm has a market cap of $2.38 billion, a PE ratio of 30.07, a PEG ratio of 2.11 and a beta of 1.01. Addus HomeCare Co. has a one year low of $85.94 and a one year high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. During the same quarter in the prior year, the firm earned $1.03 EPS. The company’s revenue for the quarter was up 7.1% on a year-over-year basis. On average, equities analysts predict that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Insider Activity

In other news, CEO R Dirk Allison sold 12,500 shares of the stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the sale, the chief executive officer now directly owns 141,897 shares in the company, valued at $17,476,034.52. This represents a 8.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the sale, the executive vice president now owns 10,217 shares of the company’s stock, valued at approximately $1,236,257. The trade was a 18.05 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 4.60% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on ADUS. Royal Bank of Canada reissued an “outperform” rating and set a $136.00 target price on shares of Addus HomeCare in a report on Thursday, November 14th. KeyCorp began coverage on Addus HomeCare in a report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price objective for the company. Macquarie restated an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research note on Monday, November 4th. Oppenheimer lifted their price target on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. Finally, StockNews.com raised Addus HomeCare from a “hold” rating to a “buy” rating in a report on Wednesday, December 11th. One equities research analyst has rated the stock with a sell rating, nine have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $133.67.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.